Molecular Imaging

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on a variety of FDA news in radiology from the past week.

Based on results from the phase III PSMAddition trial, the expanded approval may nearly double the number of patients with prostate cancer who can be treated with Pluvicto.

Catch up on the most-well viewed radiology content in July 2026.

In a comparative study involving 51 women who had systemic treatment for metastatic breast cancer, researchers found that all FDG-PET scans identified measurable target lesions according to PERCIST criteria in comparison to 35 percent of CT scans as per RECIST 1.1 criteria.

Catch up on the top radiology content of the past week.

Researchers found that former NFL players had a 3.8-fold higher mortality rate for all-cause dementia and a nearly 3.9-fold higher mortality rate for Parkinson’s disease, according to a study involving over 19,800 former NFL players.

Researchers said the combination of 18F-flotufolastat PET/MRI may lead to a 57 percent reduction of prostate biopsies in comparison to a 25 percent reduction with prostate MRI alone.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in June 2026.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in June 2026.

Catch up on the top radiology content of the past week.

In a recent episode of our “Molecular Imaging in Focus” series, Surekha Yadav, MBBS, MD, discussed research presented at the SNMMI conference that showed significant advantages of PSMA PET over conventional imaging for detection of osseous oligometastatic prostate cancer (PCa).

Catch up on the top radiology content of the past week.

The use of FAPI PET/CT offered a 97 percent pooled sensitivity for detecting peritoneal metastases in a patient-based analysis in a new meta-analysis involving over 800 patients.

In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.

In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.

Catch up on the top radiology content of the past week.

For men with high clinical risk for prostate cancer (PCa) and a lack of significant findings on mpMRI, triage use of PSMA PET/CT resulted in a 49 percent reduction of biopsies and an 18 percent reduction in detection of clinically insignificant PCa, according to newly published research.

The Reporting Pro software reportedly offers an array of AI-enabled features that may help streamline radiology reports.

Catch up on the top radiology content of the past week.

While researchers saw no significant difference in metastasis-free survival with the use of perioperative apalutamide in patients undergoing radical prostatectomy based on conventional imaging alone, the addition of PSMA PET imaging revealed a 20 percent higher likelihood of metastasis-free survival with adjunctive apalutamide.

In comparison to short-axial field of view PET/CT scanners, a total body PET/CT imaging platform with a long axis field of view detected more lesions in 68 percent of patients while reducing scan times by 83 percent, according to new research presented at the SNMMI conference.

Catch up on the top radiology content of the past week.

The SubtleHD(PET) software reportedly facilitates enhanced image quality, provides improved SUVmax quantitative accuracy and compatibility with all FDA-approved radiotracers.